Tommy G. Thompson - 24 Mar 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
24 Mar 2025
Net transactions value
-$358,416
Form type
4
Filing time
25 Mar 2025, 16:31:23 UTC
Previous filing
03 Mar 2025
Next filing
15 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $438,575 +2,500 +29% $175.43 10,980 24 Mar 2025 Direct F1
transaction UTHR Common Stock Sale $796,990 -2,500 -23% $318.80 8,480 24 Mar 2025 Direct F1, F2
holding UTHR Common Stock 8,200 24 Mar 2025 by Trust
holding UTHR Common Stock 5,800 24 Mar 2025 Family LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Option Options Exercise $0 -2,500 -50% $0.000000 2,500 24 Mar 2025 Common Stock 2,500 $175.43 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 880 shares of common stock to be issued on or about July 8, 2026, as the result of the July 7, 2023 vesting of RSUs for which the reporting person elected to defer receipt of shares.
F2 This transaction was executed in multiple trades at prices ranging from $318.43 to $319.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.